Loss of SMARCB1 evokes targetable epigenetic vulnerabilities in epithelioid sarcoma

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Jin, J. X., Fuchslocher, F., Carreno-Gonzalez, M., Zahnow, F., Ceranski, A. K., Will, R., … Grünewald, T. G. P. (2025, May 1). Loss of SMARCB1 evokes targetable epigenetic vulnerabilities in epithelioid sarcoma. Cancer Communications. John Wiley and Sons Inc. https://doi.org/10.1002/cac2.12665

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free